Blymphocytes normally respond only to foreign substances, or antigens, such as bacteria.
But in people with lupus the cells react to the body's own molecules, generating antibodies that bind to those "self-antigens" and then avvumulate in tissues.
There the antibody-antigen compleces lead to tissue damage.
Several therapies under study for lupus aim to delete B cells or to block one or another